Medical diagnostic firm Biomerica's Q1 revenue falls on lower retail activity

Reuters

Oct 15

Medical diagnostic firm Biomerica's Q1 revenue falls on lower retail activity

Overview

Biomerica fiscal Q1 revenue fell to $1.4 mln from $1.8 mln, reflecting reduced retail activity
Gross margin improved to 31% from 16%, driven by higher-margin product mix
Operating expenses decreased to $1.5 mln, highlighting cost discipline

Outlook

Biomerica did not provide specific financial guidance for future periods

Result Drivers

HIGHER-MARGIN PRODUCT MIX - Improved gross margin driven by contribution from higher-margin products
COST REDUCTION - Decline in operating expenses due to focus on cost reduction and operational efficiency
NON-RECURRING TAX CREDIT - Net profit aided by non-recurring tax credit

Key Details

Metric	Beat/Miss	Actual	Consensus Estimate
Q1 Revenue		$1.40 mln
Q1 Net Income		$0.0
Q1 Gross Margin		31%
Q1 Operating Expenses		$1.50 mln
Q1 Operating Income		-$1.10 mln

Press Release: ID:nGNXcc5s9M

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2575738507"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2575738507\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2575738507?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-15 21:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2575738507","market":"fut","top_or_hot":-1,"title":"Medical diagnostic firm Biomerica's Q1 revenue falls on lower retail activity","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Medical diagnostic firm Biomerica's Q1 revenue falls on lower retail activity</title></head><body><p><span>Overview</span></p><ul><li><p>Biomerica fiscal Q1 revenue fell to $1.4 mln from $1.8 mln, reflecting reduced retail activity</p></li><li><p>Gross margin improved to 31% from 16%, driven by higher-margin product mix</p></li><li><p>Operating expenses decreased to $1.5 mln, highlighting cost discipline</p></li></ul><p><span>Outlook</span></p><ul><li><p>Biomerica did not provide specific financial guidance for future periods</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>HIGHER-MARGIN PRODUCT MIX - Improved gross margin driven by contribution from higher-margin products</p></li><li><p>COST REDUCTION - Decline in operating expenses due to focus on cost reduction and operational efficiency</p></li><li><p>NON-RECURRING TAX CREDIT - Net profit aided by non-recurring tax credit</p></li></ul><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>Q1 Revenue</p></td><td></td><td><p>$1.40 mln</p></td><td></td></tr><tr><td><p>Q1 Net Income</p></td><td></td><td><p>$0.0</p></td><td></td></tr><tr><td><p>Q1 Gross Margin</p></td><td></td><td><p>31%</p></td><td></td></tr><tr><td><p>Q1 Operating Expenses</p></td><td></td><td><p>$1.50 mln</p></td><td></td></tr><tr><td><p>Q1 Operating Income</p></td><td></td><td><p>-$1.10 mln</p></td><td></td></tr></tbody></table><p>Press Release: <span>ID:nGNXcc5s9M</span></p><p>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.</p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Medical diagnostic firm Biomerica's Q1 revenue falls on lower retail activity</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMedical diagnostic firm Biomerica's Q1 revenue falls on lower retail activity\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-15 21:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Medical diagnostic firm Biomerica's Q1 revenue falls on lower retail activity</title></head><body><p><span>Overview</span></p><ul><li><p>Biomerica fiscal Q1 revenue fell to $1.4 mln from $1.8 mln, reflecting reduced retail activity</p></li><li><p>Gross margin improved to 31% from 16%, driven by higher-margin product mix</p></li><li><p>Operating expenses decreased to $1.5 mln, highlighting cost discipline</p></li></ul><p><span>Outlook</span></p><ul><li><p>Biomerica did not provide specific financial guidance for future periods</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>HIGHER-MARGIN PRODUCT MIX - Improved gross margin driven by contribution from higher-margin products</p></li><li><p>COST REDUCTION - Decline in operating expenses due to focus on cost reduction and operational efficiency</p></li><li><p>NON-RECURRING TAX CREDIT - Net profit aided by non-recurring tax credit</p></li></ul><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>Q1 Revenue</p></td><td></td><td><p>$1.40 mln</p></td><td></td></tr><tr><td><p>Q1 Net Income</p></td><td></td><td><p>$0.0</p></td><td></td></tr><tr><td><p>Q1 Gross Margin</p></td><td></td><td><p>31%</p></td><td></td></tr><tr><td><p>Q1 Operating Expenses</p></td><td></td><td><p>$1.50 mln</p></td><td></td></tr><tr><td><p>Q1 Operating Income</p></td><td></td><td><p>-$1.10 mln</p></td><td></td></tr></tbody></table><p>Press Release: <span>ID:nGNXcc5s9M</span></p><p>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.</p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BMRA","symbol_name":"Biomerica Inc","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251015:nL2N3VW0IG:1","article_id":"2575738507","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2575738507","pubTimestamp":1760535415,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Medical diagnostic firm Biomerica's Q1 revenue falls on lower retail activityOverviewBiomerica fiscal Q1 revenue fell to $1.4 mln from $1.8 mln, reflecting reduced retail activityGross margin improved","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BMRA":"Biomerica Inc","BK4082":"医疗保健设备"},"translate_title":"医疗诊断公司Biomerica第一季度收入因零售活动下降而下降","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BMRA":0.9},"content_text":"Medical diagnostic firm Biomerica's Q1 revenue falls on lower retail activityOverviewBiomerica fiscal Q1 revenue fell to $1.4 mln from $1.8 mln, reflecting reduced retail activityGross margin improved to 31% from 16%, driven by higher-margin product mixOperating expenses decreased to $1.5 mln, highlighting cost disciplineOutlookBiomerica did not provide specific financial guidance for future periodsResult DriversHIGHER-MARGIN PRODUCT MIX - Improved gross margin driven by contribution from higher-margin productsCOST REDUCTION - Decline in operating expenses due to focus on cost reduction and operational efficiencyNON-RECURRING TAX CREDIT - Net profit aided by non-recurring tax creditKey DetailsMetricBeat/MissActualConsensus EstimateQ1 Revenue$1.40 mlnQ1 Net Income$0.0Q1 Gross Margin31%Q1 Operating Expenses$1.50 mlnQ1 Operating Income-$1.10 mlnPress Release: ID:nGNXcc5s9MFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}